转自：北京日报客户端 今年初，瑞迈特、子公司天津怡和嘉业、北京朝阳医院等单位联合申报的"无创呼吸系统关键技术研发 与临床应用"项目被天津市科学技术局评定为"科技进步奖"一等奖。北京朝阳医院呼吸与危重症医学科 主任曹志新介绍，只有充分发挥"医工结合"的优势，才能更好地把本土医疗实践与研发相结合，针对中 国特色的需求，打造出更适合的产品和服务，解决好临床前沿最迫切的需求。这只有国产的领军企业联 合国内优质医疗资源才能做到，从而构建起一个高效、人性化的呼吸健康管理新范式。 来源：北京日报客户端 "在我们创业初期，家用呼吸机市场被国际企业垄断，中国相关产业链几乎为零，核心技术与部件受制 于人，国产品牌举步维艰，用户不得不以高昂价格购买国外产品。"BMC瑞迈特执行副总经理周明钊在 活动演讲中说道。面对这一局面，公司选择了一条最艰难但也最坚实的道路——正向研发，从底层技术 破局。 回顾二十余年的发展历程，一条清晰的主线贯穿始终——对核心技术自主研发的坚持与不懈投入。公司 从被誉为"呼吸机心脏"的风机入手，与供应链伙伴联合开发，实现了核心部件的国产化，并持续迭代， 如今其风机在转速、稳定性与噪音控制上已可比肩国际顶尖水平。 ...

Core Insights - The article highlights the strategic advancements and achievements of Beijing Ruimait Medical Technology Co., Ltd. in the respiratory health sector, showcasing its position as a leading domestic manufacturer of home ventilators in China and the second globally [1] Group 1: Technological Innovation and Market Expansion - Ruimait has established itself as the only Chinese company among the top five global home ventilator manufacturers, focusing on respiratory issues such as COPD and obstructive sleep apnea since its founding in 2001 [2] - The company has achieved significant technological milestones, including being the first Chinese brand to receive FDA certification for home ventilators in 2012, and has accumulated 932 domestic and international patents by June 30, 2025 [2][3] - Ruimait's home ventilators have sold over 3 million units globally, with more than 10 million masks sold, demonstrating its extensive market reach [2] Group 2: Commitment to R&D and Industry Standards - The company emphasizes its commitment to independent R&D, particularly in core technologies, which has led to the localization of key components and significant improvements in product performance [3] - Ruimait has contributed to the establishment of 38 industry standards, enhancing the quality and competitiveness of Chinese respiratory health products in the global market [4] Group 3: Ecosystem Development and Comprehensive Solutions - Ruimait is expanding its capabilities beyond single devices to comprehensive respiratory health management solutions, aiming to become a preferred platform for global respiratory health management [5] - The introduction of the "smart mobile oxygen supply combination scheme" reflects the company's understanding of user needs and its ability to integrate technology across various products [6] - The establishment of a respiratory health management cloud platform in 2015 has enabled remote monitoring and intervention, transforming traditional respiratory devices into integrated management solutions [6] Group 4: Clinical Integration and User-Centric Approach - The integration of medical and engineering expertise is crucial for developing products that meet local healthcare needs, as emphasized by clinical experts [7] - Ruimait's product evolution from single devices to comprehensive solutions across various settings demonstrates its commitment to enhancing patient quality of life and effective health management [8]

工程院院士倪光南在接受采访时表示：核心技术买不来、讨不来，反对"披马甲"的国产技术。他认为， 华为是中国目前最伟大的公司。 三、华为是中国最伟大的企业 以下是倪光南的采访言论： 一、反对"披马甲"的国产技术 倪光南：有些人真是不太好讲，有些人就是用穿马甲的吧，穿马甲就很形象，把外国的技术啊，把它打 扮成国产的，披个"马甲"就是挺好，这是外国技术，我已经国产化了，那这样呢，就有一个借口可以不 用国产的技术。 倪光南：客观上这种情况还比较多，在我们这个领域，就是你发现国产技术推不出去，人家不是说你不 好，而是说我这个技术，把穿马甲的技术冒充国产技术，你用了这个技术，技术人家掌握不是你的，他 就远程可以叫你停止工作，或者叫你出错，就是瘫痪，所以这是很大风险，安全风险。 二、核心技术要不来，买不来，跑不来 倪光南：这些技术是要不来，买不来，跑不来。过去一个计算机最早的时候，一个篮球场那么大，人家 不会卖给你，大型计算机对中国禁用，那么我们国家两弹一星，那些重大的科技需要计算该怎么办呢？ 那么我们就得要给国家搞计算机，自己要从零开始做，等到我们国家做出了一个水平的计算机，人家就 把同样等级的计算机卖给你了，不到这个水平 ...